C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 85 filers reported holding C4 THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $11,671,000 | -24.7% | 481,094 | 0.0% | 2.61% | -27.3% |
Q4 2021 | $15,491,000 | -27.9% | 481,094 | 0.0% | 3.59% | -36.7% |
Q3 2021 | $21,495,000 | +18.1% | 481,094 | 0.0% | 5.67% | -10.7% |
Q2 2021 | $18,205,000 | +2.3% | 481,094 | 0.0% | 6.34% | -10.5% |
Q1 2021 | $17,795,000 | +11.6% | 481,094 | 0.0% | 7.09% | -18.2% |
Q4 2020 | $15,939,000 | – | 481,094 | – | 8.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 481,094 | $15,939,000 | 8.67% |
Bain Capital Life Sciences Investors, LLC | 1,642,209 | $54,406,000 | 3.42% |
Darwin Global Management, Ltd. | 228,595 | $7,573,000 | 2.11% |
Asymmetry Capital Management, L.P. | 139,343 | $4,616,000 | 2.10% |
Cormorant Asset Management, LP | 2,490,065 | $80,021,000 | 1.90% |
Logos Global Management LP | 477,928 | $15,834,000 | 1.36% |
SPHERA FUNDS MANAGEMENT LTD. | 443,824 | $14,601,000 | 1.30% |
Soleus Capital Management, L.P. | 268,548 | $8,897,000 | 1.17% |
P.A.W. CAPITAL CORP | 40,000 | $1,325,000 | 1.17% |
RTW INVESTMENTS, LP | 2,149,228 | $68,679,000 | 1.15% |